A few years ago, when most investors were focused on the short term, I was reviewing what the best options were to invest in 2024 and beyond. The interesting thing is that many of those bets I made back then turned out to be quite solid.

Alphabet was one of my favorites. The company simply dominates the digital ecosystem with Google, YouTube, Android, and Chrome. What caught my attention was its aggressive artificial intelligence strategy with Gemini, trying to compete directly with ChatGPT. Additionally, its free cash flow exceeded $77 billion, giving it enough ammunition to innovate without pressure. The P/E ratio hovered around 29, lower than the sector average, so there was real growth potential.

Nvidia was another strong bet. With nearly 90% of the AI chip market, it was practically impossible to ignore. What happened afterward confirmed what many of us saw: GPU demand simply exploded. The technical momentum was incredible; the stocks constantly broke their moving averages. In 2023, it grew 239%, so it was already at a high level, but the potential was still there.

Then there was Novo Nordisk, which I found to be an interesting discovery. The anti-obesity drug market was just beginning. With Ozempic leading, the company was in the right position at the right time. The market projected to reach $44 billion by 2030, so the runway was long. Its numbers in 2023 showed a 29% sales growth and 47% profit growth in the first nine months.

Berkshire Hathaway represented the conservative side of my portfolio. Warren Buffett managing $157 billion in cash was like having a safety cushion. The beta of 0.64 meant it experienced less volatility than the overall market, perfect for those seeking peace of mind.

Broadcom was the surprise. Its acquisition of VMware was strategic, diversifying beyond semiconductors. With 108% growth in 2023 and projections of 40% for fiscal year 2024, the company was in serious expansion mode.

Now, regarding what to invest in 2024, the strategy depended on your profile. If you were short-term, CFDs offered flexibility to play with fluctuations. Geopolitical conflicts, central bank movements, and U.S. elections generated volatility that could be exploited. But honestly, CFDs amplify both gains and losses, so discipline was required.

For medium and long-term investing, the clear recommendation was diversification. Concentrating everything in a single stock was risky. The smart move was to distribute among Novo Nordisk in pharmaceuticals, Nvidia and Alphabet in AI and technology, Berkshire Hathaway in finance, and Broadcom in semiconductors. That gave you exposure to various sectors without betting everything on one card.

The most important thing was not to get carried away by daily volatility. You had to focus on fundamentals, long-term growth projections, and each company's track record. Choosing a regulated and trustworthy broker was essential, and then simply maintaining patience.

Looking back, those options for what to invest in 2024 turned out to be sound decisions. The AI market continued its expansion, Novo Nordisk kept gaining ground in anti-obesity, and solid companies like Berkshire Hathaway maintained their stability. The lesson was clear: strategic analysis, diversification, and patience. That always works.